Biggest News Aggregation in the World
📰 Jeff Fairman News

Jeff Fairman News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jeff Fairman. Real-time updates on events, politics, business and more.

Jeff Fairman Sells 4,112 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 4,112 shares of Vaxcyte stock in a transaction on Friday, May 20th. The stock was sold at an average price of $25.50, for a total transaction of $104,856.00. Following the transaction, the vice president now directly owns 321,227 shares in the company, valued at $8,191,288.50. […]
Jeff Fairman Zacks Investment Research Blackrock Inc Vanguard Group Inc Needham Company Frazier Life Sciences Management

Insider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) VP Sells 5,000 Shares of Stock

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 5,000 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $25.59, for a total value of $127,950.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is […]
United States Jeff Fairman Groupa Strep Morgan Stanley Securities Exchange Commission Zacks Investment Research

Vaxcyte (NASDAQ:PCVX) Shares Gap Up to $25.68

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $25.68, but opened at $26.55. Vaxcyte shares last traded at $26.38, with a volume of 1,109 shares traded. Several research firms have recently commented on PCVX. Zacks Investment Research downgraded shares of […]
Paul Sauer Jeff Fairman Groupa Strep Zacks Investment Research Ensign Peak Advisors Inc Needham Company

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Equities Analysts Offer Predictions for Vaxcyte, Inc.'s FY2022 Earnings (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) – Equities researchers at Jefferies Financial Group lowered their FY2022 earnings estimates for shares of Vaxcyte in a report issued on Monday, February 28th. Jefferies Financial Group analyst R. Song now forecasts that the company will post earnings per share of ($2.38) for the year, down from their previous […]
Jim Wassil Jeff Fairman Groupa Strep Northern Trust Corp Geode Capital Management Goldman Sachs Group Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science